Virtus ETF Advisers LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 79 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$258,000
-48.4%
44,364
-8.4%
0.11%
-44.7%
Q2 2021$500,000
+18.2%
48,428
+20.5%
0.21%
+15.1%
Q1 2021$423,000
-30.1%
40,187
+2.8%
0.18%
-28.7%
Q4 2020$605,000
+18.4%
39,090
+11.7%
0.25%
-6.3%
Q3 2020$511,000
-15.8%
34,998
+9.2%
0.27%
-6.6%
Q2 2020$607,000
-10.1%
32,050
-8.8%
0.29%
+3.2%
Q1 2020$675,000
-7.5%
35,134
-7.8%
0.28%
+133.6%
Q4 2019$730,000
+71.4%
38,098
-13.9%
0.12%
+38.4%
Q3 2019$426,000
+52.1%
44,246
-5.3%
0.09%
+45.8%
Q2 2019$280,000
+75.0%
46,711
+70.5%
0.06%
-82.6%
Q1 2019$160,000
-44.4%
27,391
-10.9%
0.34%
+593.9%
Q4 2018$288,000
-35.6%
30,726
+17.1%
0.05%
+6.5%
Q3 2018$447,000
-41.5%
26,238
-41.7%
0.05%
-93.2%
Q2 2018$764,000
-30.0%
44,986
-44.7%
0.68%
-28.7%
Q1 2018$1,091,000
+207.3%
81,325
+120.0%
0.95%
+112.8%
Q4 2017$355,000
-9.7%
36,973
+3.3%
0.44%
+739.6%
Q3 2017$393,000
+33.7%
35,776
+10.1%
0.05%
+20.5%
Q2 2017$294,000
-24.6%
32,504
+7.1%
0.04%
-36.2%
Q1 2017$390,000
+51.2%
30,356
+10.6%
0.07%
-10.4%
Q4 2016$258,000
-13.4%
27,446
-10.4%
0.08%
-46.5%
Q3 2016$298,000
+45.4%
30,6170.0%0.14%
-5.3%
Q2 2016$205,000
+28.1%
30,617
+70.8%
0.15%
-30.9%
Q1 2016$160,00017,9230.22%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders